Skip to content

DMT: all studies

Page 38 of 160: studies 371 to 380 of 1,593, newest first. Back to the DMT overview

Research

Noncompetitive inhibition of indolethylamine-N-methyltransferase by N,N-dimethyltryptamine and N,N-dimethylaminopropyltryptamine.

Biochemistry May 13, 2014 Uyen B Chu, Sevahn K Vorperian, Kenneth Satyshur et al.

Indolethylamine-N-methyltransferase (INMT) is a Class 1 transmethylation enzyme known for its production of N,N-dimethyltryptamine (DMT), a hallucinogen with affinity for various serotonergic, adrenergic, histaminergic, dopaminergic, and sigma-1 receptors. DMT is produced via the action of INMT on the endogenous substrates tryptamine and S-adenosyl-l-methionine (SAM). The biological,...

Biosynthesis of N,N-dimethyltryptamine (DMT) in a melanoma cell line and its metabolization by peroxidases.

Biochemical Pharmacology April 1, 2014 Melissa M. Gomes, J. B. Coimbra, R. O. Clara et al. 21 citations

Tryptophan (TRP) is essential for many physiological processes, and its metabolism changes in some diseases such as infection and cancer. The most studied aspects of TRP metabolism are the kynurenine and serotonin pathways. A minor metabolic route, tryptamine and N,N-dimethyltryptamine (DMT) biosynthesis, has received far less attention, probably because of the very low amounts of these...

DMT, Ecocide, and the Western Psyche

Clio's Psyche 2014 Sebastian Job

Plagued by fears of civilizational collapse, the human relation to nature is charging back into modern consciousness. The natural sciences alert us to calamities on a vast scale, yet court the suspicion that they themselves presuppose an attitude intrinsic to the destructive dynamic. Thoughtful people diagnose a spiritual malaise at the heart of modern western culture. They wonder aloud how...

Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells.

PLoS One 2014 Attila Szabo, Attila Kovács, Ede Frecska et al. 191 citations

The orphan receptor sigma-1 (sigmar-1) is a transmembrane chaperone protein expressed in both the central nervous system and in immune cells. It has been shown to regulate neuronal differentiation and cell survival, and mediates anti-inflammatory responses and immunosuppression in murine in vivo models. Since the details of these findings have not been elucidated so far, we studied the effects...

Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample

Journal of Psychopharmacology November 27, 2013 Adam Winstock, Stephen J. Kaar, Rohan Borschmann 101 citations

This paper presents original research on prevalence, user characteristics and effect profile of N,N-dimethyltryptamine (DMT), a potent hallucinogenic which acts primarily through the serotonergic system. Data were obtained from the Global Drug Survey (an anonymous online survey of people, many of whom have used drugs) conducted between November and December 2012 with 22,289 responses. Lifetime...

Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells.

Cell biochemistry and function July 2013 Melissa Cavalheiro Tourino, Edson Mendes De Oliveira, Luziane Potrich Bellé et al.

Indoleamine 2,3-dioxygenase (IDO) is an interferon-γ (IFN-γ)-induced tryptophan-degrading enzyme, producing kynurenine (KYN) that participates in the mechanism of tumor immune tolerance. Thus, IDO inhibition has been considered a strategy for anticancer therapy. The aim of this study was to identify whether the metabolites originated from the competitive routes of tryptophan metabolism, such as...

DOI: 10.1002/cbf.2980 (opens in new tab) Full text (opens in new tab) Immune escape Kynurenine pathway Tolerance Tryptophan metabolism +1

Pharmacokinetic interactions between monoamine oxidase A inhibitor harmaline and 5-methoxy-N,N-dimethyltryptamine, and the impact of CYP2D6 status.

Drug Metabolism and Disposition May 1, 2013 Xi-Ling Jiang, Hong-Wu Shen, Donald E. Mager et al. 29 citations

5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT or street name "5-MEO") is a newer designer drug belonging to a group of naturally occurring indolealkylamines. Our recent study has demonstrated that coadministration of monoamine oxidase A (MAO-A) inhibitor harmaline (5 mg/kg) increases systemic exposure to 5-MeO-DMT (2 mg/kg) and active metabolite bufotenine. This study is aimed at delineating...

DOI: 10.1124/dmd.112.050724 (opens in new tab) Full text (opens in new tab) Pharmacokinetics Drug interactions Drug metabolism Designer drugs

A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity.

Journal of Neural Transmission April 26, 2013 Ede Frecska, Attila Szabo, Michael J. Winkelman et al. 107 citations

N,N-dimethyltryptamine (DMT) is classified as a naturally occurring serotonergic hallucinogen of plant origin. It has also been found in animal tissues and regarded as an endogenous trace amine transmitter. The vast majority of research on DMT has targeted its psychotropic/psychedelic properties with less focus on its effects beyond the nervous system. The recent discovery that DMT is an...

DOI: 10.1007/s00702-013-1024-y (opens in new tab) DMT N-dimethyltryptamine Therapeutic potential Medical applications +19

Investigations into the polymorphic properties of N,N-dimethyltryptamine by X-ray diffraction and differential scanning calorimetry

Microchemical Journal March 20, 2013 Alain Gaujac, James L. Ford, Nicola M. Dempster et al. 10 citations

The powerful psychoactive features of N,N-dimethyltryptamine (DMT) have sparked the imagination of many research disciplines for several decades. One of the key chemical features associated with compound identity is the determination of melting points. The descriptions of both melting points and morphology associated with DMT free base have long been a source of interest and discussion,...

DOI: 10.1016/j.microc.2013.03.009 (opens in new tab) Differential scanning calorimetry Acetonitrile Recrystallization geology Melting point +7

Determination of N,N-dimethyltryptamine in beverages consumed in religious practices by headspace solid-phase microextraction followed by gas chromatography ion trap mass spectrometry

Talanta February 1, 2013 Alain Gaujac, Nicola M. Dempster, Sandro Navickiene et al. 29 citations

A novel analytical approach combining solid-phase microextraction (SPME)/gas chromatography ion trap mass spectrometry (GC-IT-MS) was developed for the detection and quantification N,N-dimethyltryptamine (DMT), a powerful psychoactive indole alkaloid present in a variety of South American indigenous beverages, such as ayahuasca and vinho da jurema. These particular plant products, often used...

DOI: 10.1016/j.talanta.2013.01.017 (opens in new tab) Solid-phase microextraction Gas chromatography–mass spectrometry Ion trap Detection limit